Safety of Peptide Receptor Radionuclide Therapy with


Journal

Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410

Informations de publication

Date de publication:
10 2022
Historique:
received: 16 08 2021
accepted: 10 02 2022
pubmed: 26 2 2022
medline: 6 10 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

Our purpose was to assess the efficacy and safety of

Identifiants

pubmed: 35210299
pii: jnumed.121.263056
doi: 10.2967/jnumed.121.263056
pmc: PMC9536708
doi:

Substances chimiques

Radioisotopes 0
Radiopharmaceuticals 0
Receptors, Peptide 0
copper dotatate CU-64 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1503-1508

Informations de copyright

© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Références

Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):490-499
pubmed: 27704193
J Clin Oncol. 2008 May 1;26(13):2124-30
pubmed: 18445841
Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):38-46
pubmed: 28864881
Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1854-60
pubmed: 17546456
Eur J Nucl Med Mol Imaging. 2013 May;40(5):800-16
pubmed: 23389427
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Eur J Nucl Med Mol Imaging. 2014 May;41(5):925-33
pubmed: 24504504
J Nucl Med. 2005 Jan;46 Suppl 1:83S-91S
pubmed: 15653656
Eur J Nucl Med. 1999 Nov;26(11):1439-47
pubmed: 10552085
Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1480-1489
pubmed: 28331954
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Clin Oncol. 2018 Sep 1;36(25):2578-2584
pubmed: 29878866
Semin Nucl Med. 2016 Sep;46(5):462-78
pubmed: 27553471
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1802-11
pubmed: 27160225
J Am Geriatr Soc. 1985 Apr;33(4):278-85
pubmed: 3989190
Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):5-19
pubmed: 25273832
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
J Nucl Med. 2002 May;43(5):610-6
pubmed: 11994522
Neuroendocrinology. 2021;111(4):330-343
pubmed: 32097917
J Nucl Med. 2014 Feb;55(2):183-90
pubmed: 24434296
Trans Am Clin Climatol Assoc. 2009;120:419-28
pubmed: 19768194
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):453-63
pubmed: 26419852
Eur J Nucl Med Mol Imaging. 2015 May;42(6):947-55
pubmed: 25655484

Auteurs

Shahad Alsadik (S)

Neuroendocrine Unit, Royal Free London NHS Foundation Trust, London, United Kingdom; s.navalkissoor@nhs.net s.alsadik@nhs.net.

Gopinath Gnanasegaran (G)

Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom.

Luohai Chen (L)

Department of Gastroenterology, Royal Free London NHS Foundation Trust, London, United Kingdom; and.
First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.

Dalvinder Mandair (D)

Neuroendocrine Unit, Royal Free London NHS Foundation Trust, London, United Kingdom.

Christos Toumpanakis (C)

Neuroendocrine Unit, Royal Free London NHS Foundation Trust, London, United Kingdom.

Martyn Caplin (M)

Neuroendocrine Unit, Royal Free London NHS Foundation Trust, London, United Kingdom.

Shaunak Navalkissoor (S)

Department of Nuclear Medicine, Royal Free London NHS Foundation Trust, London, United Kingdom; s.navalkissoor@nhs.net s.alsadik@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH